Skip to main content

UKHSA invests in new system to support response to health threats

Maven® by Conduent has been selected as the new Case and Incident Management System (CIMS) that will replace the UKHSA’s current system

LONDON and FLORHAM PARK, N.J., Nov. 16, 2021 (GLOBE NEWSWIRE) — In response to the COVID-19 pandemic, the Government pledged to strengthen health protection systems. The delivery of the new CIMS platform is an important part of building on the UK’s excellent track record in dealing with health protection situations and events and will enable the UK Health Security Agency (UKHSA) to effectively monitor, identify and be ready to respond to health threats, now and in the future.

UKHSA will be deploying a system called Maven®, developed by Conduent Incorporated (Nasdaq: CNDT), as its primary platform for case, outbreak and incident management. Initially the platform will be used to track and monitor acute respiratory infections, including COVID-19, but will expand its use for case and incident management of other communicable diseases and health hazards by winter 2022.

Since the flu pandemic in 2009, the current system has been a vital tool in public health management. It has been a critical part of England’s public health management capabilities, enabling teams across the country to manage cases, identify outbreaks and work with local partners to deliver public health interventions. However, since its deployment there have been significant advancements in technology that are now available in the market. The new system will deliver in-house configurability providing greater autonomy, advanced integration capability, greater efficiency in data entry and centralised reporting functionality as well as streamlined workflows and many other features.

Dr William Welfare, Pan-Regional Director at UKHSA said:

“UKHSA is on the frontline protecting the nation from infectious diseases and other public health threats.

“Throughout this pandemic, it has been critical for us to rapidly and effectively detect and track COVID-19, share information, and respond to protect the public.

“Investing in state-of-the-art technologies, such as Conduent’s Maven, will modernise our surveillance, case and incident management capabilities keeping us at the forefront of health protection.

“This investment is crucial and I’m delighted that the UKHSA has the opportunity to deploy this system to monitor and respond to diseases that impact on people’s daily lives.”

Mark King, President, Government Solutions at Conduent said:   

“Conduent brings nearly four decades of experience supporting the public health and human services sector.

“Maven is an interoperable disease management platform that can significantly transform how public health organizations monitor and respond to diseases by getting the right information to the right people at the right time.

“We are proud to work with UKHSA as they maintain a relentless focus on keeping the citizens of and visitors to England safe and healthy.”

Maven has been in use globally for the purposes of Public Health Infectious Disease Case and Incident Management for over 18 years. The platform is currently used by approximately 40 organisations around the world. In the U.S., more than a dozen jurisdictions are using the full Maven application for COVID-19.

Notes to editors

  • The Maven® platform was selected following a competitive procurement process using an existing government framework
  • Additional details including the contract that has been awarded are available here
  • UKHSA’s current system is supplied by InFact and is called HPZone

About UK Health Security Agency

The UK Health Security Agency (UKHSA) is an executive agency of the Department of Health and Social Care. The UKHSA is responsible for planning, preventing and responding to external health threats, and providing intellectual, scientific and operational leadership at national and local level, as well as on the global stage.

About Conduent

Conduent delivers mission-critical services and solutions on behalf of businesses and governments – creating exceptional outcomes for its clients and the millions of people who count on them. Through process, technology, and our diverse and dedicated associates, Conduent solutions and services automate workflows, improve efficiencies, reduce costs and enable revenue growth. It’s why most Fortune 100 companies and over 500 government entities depend on Conduent every day to manage their essential interactions and move their operations forward.

Conduent’s differentiated services and solutions improve experiences for millions of people every day, including three out of every four U.S. insured patients, 10 million employees who use its HR Services, and nearly 18 million benefits recipients. Conduent’s solutions deliver exceptional outcomes for its clients including $16 billion in savings from medical bill review of workers compensation claims, up to 40% efficiency increase in HR operations, up to 27% reduction in government benefits costs, up to 40% improvement in finance, accounting and procurement expense, and improved customer service interaction times by up to 20% with higher end-user satisfaction. Learn more at www.conduent.com.

UK Health Security Agency contacts

Email: UKHSA-pressoffice@phe.gov.uk

Telephone: 020 7654 8400/020 8200 4400 (out of hours)

Conduent Media Contacts

Robert Corbishley, Conduent, +44 (0)7703 516569, robert.corbishley@conduent.com

Sharon Lakes, Conduent, +1-214-592-7637, Sharon.Lakes2@conduent.com

Investor Relations Contacts

Giles Goodburn, Conduent, +1-203-216-3546, ir@conduent.com

To receive RSS news feeds, visit www.news.conduent.com. For open commentary, industry perspectives and views, visit http://twitter.com/Conduent, http://www.linkedin.com/company/conduent or http://www.facebook.com/Conduent.

Conduent is a trademark of Conduent Incorporated in the United States, United Kingdom and/or other countries.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.